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ABSTRACT: 
 
Background: Various antioxidnats  from  daily  foods  are expected to  prevent  lifestyle-related 
diseases.  For  example,  natural  carotenoid  beta-cryptoxanthin  seems  to  be  a  promising 
antioxidant,  and  based  upon  epidemiological  data  it  was  shown  to  be  a  possible  cancer 
preventing agent. For this reason, we chose to study beta-cryptoxanthin more extensively. 
 
Methods  and  Results:  From  the  result  of  clinical  trial  using  beta-cryptoxanthin-enriched 
Mandarin orange juice, it was proven to potentiate the preventive activity of multi-carotenoid 
mixture against liver cancer in the patients with chronic viral hepatitis-induced liver cirrhosis. 
Furthermore, beta-cryptoxanthin also has preventive activity against alcohol-induced gamma-
GTP elevation, and obesity. 
 
Conclusion: An antioxidant beta -cryptoxanthin seems to be valuable for health promotion. 
 
Key  words:  beta-Cryptoxanthin,  Health  promotion,  Liver  cancer  prevention,  Prevention  of   
alcohol-induced gamma-GTP elevation, Prevention of obesity. 
 
 
INTRODUCTION: 
Lifestyle-related  diseases,  such  as  cancer,  metabolic  syndrome,  alcohol-induced  liver 
dysfunction, and others, are constantly increasing. Therefore, development of the methods to 
prevent these lifestyle-related diseases is very important. It is our aim to aid in lowering the Functional Foods in Health and Disease 2011,1(12):574-581                      Page 575 of 581   
 
 
incidence of these diseases through the use of various food factors which include carotenoids, 
flavonoids,  terpenoids,  etc.  Previously  in  our  laboratory,  we  found  that  an  antioxidant  beta-
cryptoxanthin  is  a  multi-functional  food  factor,  and  seems  valuable  in  controlling  various 
lifestyle-related diseases. 
Since the incidence of hepatocellular carcinoma in chronic viral hepatitis patients  with 
cirrhosis has been known to be very high, it would be valuable to find an effective method for its 
prevention. Although interferon treatment has been proven to be effective, many patients are 
non-responsive and/or intolerable to its strong side effects. Therefore, alternative methods may 
prove beneficial and should be developed. It has been suggested   that diets rich in fruits and 
vegetables can reduce the risk of various types of cancer, and that some phytochemicals in fruits 
and vegetables may play important roles for this risk reduction. For instance, carotenoids have 
been studied as possible candidates for cancer prevention. Initially, carotenoids were thought to 
be  important  precursors  of  vitamin A.  In  this  context,  beta-carotene  has  been  studied  most 
extensively,  because  beta-carotene  has  the  highest  provitamin A  activity  among  carotenoids. 
However, it has been   suggested that beta-carotene itself could have a protective effect against 
cancer without converting to vitamin A [1]. Then, it was shown that various carotenoids other 
than beta-carotene may also play important role in cancer prevention. Our laboratory has found     
that alpha-carotene and lycopene showed higher activity than beta-carotene in the suppression of 
tumorigenesis in various organs [2]. And we have found that a mixture of carotenoids, consisting 
of lycopene, alpha-carotene and beta-carotene and minor portions of other carotenoids such as 
phytoene  and  phytofluene,  prevents  liver  cancer  in  patients  with  chronic  viral  hepatitis  and 
cirrhosis.  In  addition  to  alpha-carotene  and  lycopene,  other  carotenoids,  such  as  beta-
cryptoxanthin, also seem to be promising carotenoids. Because beta-cryptoxanthin was shown to 
be  a  possible  candidate  as  a  cancer  preventor,  based  on  many  epidemiological  data  [3-9]. 
Furthermore, besides these carotenoids, various other phytochemicals, including myo-inositol, 
were also shown to have cancer preventive activities [10]. Based on these data, we examined the 
effect of the administration of a mixture of beta-cryptoxanthin and myo-inositol in addition to 
above mentioned carotenoid mixture (lycopene, alpha-carotene and, and beta-carotene) on liver 
carcinogenesis to improve the efficiency for liver cancer prevention in patients with chronic viral 
hepatitis and cirrhosis. In this report, brief summary of the study is shown. beta-Cryptoxanthin 
has also been found to prevent metabolic syndrome, and alcohol induced liver dysfunction. Some 
of these effects of beta-cryptoxanthin is also shown and discussed. 
 
MATERIALS AND METHODS: 
1. Animal experiment: Spontaneous liver carcinogenesis model was used. Male C3H/He mice 
that have a high incidence of spontaneous liver tumors were treated for 40 weeks   with alpha-
and beta-carotene (at the concentration of 0.05%, mixed as emulsion into drinking water) or 
vehicle as a control. 
 
2. Clinical study: The study protocol was approved by the review board for research on human 
subjects, and written informed consent was obtained from each patient. Functional Foods in Health and Disease 2011,1(12):574-581                      Page 576 of 581   
 
 
In the first trial, patients who have viral hepatitis with cirrhosis were randomly assigned to 
two groups. Since the study was randomized, the groups were well-balanced with respect to the 
stage of hepatitis, cirrhosis and other fundamental status. Furthermore subject compliance was 
assessed  at  each  visit  for  clinical  follow  up.  Patients  in  Group  1  were  administered  the 
carotenoids mixture, in addition to conventional anti-symptomatic treatment. Patients in Group 2 
(the  control  group)  were  treated  with  anti-symptomatic  treatment  alone.  These  groups  were 
followed up    for 2 ~ 5 years (3.4 years in average), and hepatocellular carcinoma development 
was clinically analyzed and recorded utilizing imaging and serum marker studies. Cumulative 
incidence of hepatocellular carcinoma development was plotted by Kaplan-Meier method, and 
compared between the two groups. 
In the second trial, Mandarin orange juice enriched by beta-cryptoxanthin and myo-inositol 
was administered with the carotenoids mixture used in the first trial. Follow-up schedule was the 
same as the first trial. 
 
    3.  Clinical  trial  for  lifestyle-related  diseases  using  beta-cryptoxanthin-rich  Mandarin 
orange    juice:  beta-Cryptoxanthin-rich  Mandarin  orange    juice  (3mg  beta-cryptoxanthin  in 
80ml) was administered to men with obesity (body weight elevation, and high BMI), or with  
alcohol-induced gamma-GTP elevation as well as obesity. 
 
RESULTS: 
1. Phytochemicals for liver cancer prevention: At first, we evaluated the anti-carcinogenic 
activity of various natural carotenoids, and found that alpha-carotene showed higher activity than 
beta-carotene to suppress liver carcinogenesis, as shown in Table 1. 
 
Table 1. Effect of phytochemicals on spontaneous liver carcinogenesis in C3H/He male mice 
__________________________________________________________________________ 
Condition                  (n)         Mean number of tumors per mouse     (Inhibition %) 
__________________________________________________________________________ 
Exp. 1 
Control                   (16)                          6.3 
+alpha-Carotene     (17)                         3.0*                                             (52%) 
+beta-Carotene       (17)                         4.7                                               (25%) 
 
Exp. 2 
Control                    (17)                         7.7 
+Lycopene              (13)                         0.9*                                             (88%) 
 
Exp. 3 
Control                    (17)                         7.8 
+myo-Inositol       （13）                      0.8*                                             (90%) 
__________________________________________________________________________ 
 
*p<0.05, comparing with control group. Functional Foods in Health and Disease 2011,1(12):574-581                      Page 577 of 581   
 
 
 
Exp. 1. alpha-and beta-Carotene: 0.05% in drinking water, given during the entire experimental 
period. 
 
Exp.2. Lycopene: 0.005% in drinking water, given during the entire experimental period. 
 
Exp. 3. myo-Inositol: 1% in drinking water, given during the entire experimental period. 
 
The  mean  number  of  hepatomas  was  significantly  decreased  by  alpha-carotene  treatment  as 
compared with that in the control group. On the other hand, the beta-carotene-treated group did 
not show a significant difference from the control group, although a tendency toward a decrease 
was observed.   
Furthermore,  lycopene  was  also  found  to  have  very  high  potential  for  liver  cancer 
prevention (Table 1). In the case of beta-cryptoxanthin, we have found that the plasma level of 
beta-cryptoxanthin, besides hydrocarbon carotenoids, is lower in liver cancer patients compared 
with that of healthy individuals, as shown in Table 2. 
 
Table 2. Concentration of beta-cryptoxanthin in serum (Case-control study) 
___________________________________________________________________________ 
Group                                (n)                Concentration of serum beta-cryptoxanthin (g/ml) 
___________________________________________________________________________ 
Control                             (51)                                             0.68 
 
Liver cancer patient         (21)                                             0.39* 
____________________________________________________________________________ 
*p<0.05, comparing with control group. 
 
In  addition  to  carotenoids,  other  phytochemicals,  such  as  myo-inositol  was  also  found  to 
suppress liver carcinogenesis (Table 1). Studies of cancer prevention by myo-inositol have their 
origin  in  the  results  of  inositol  hexaphosphate  (phytate).  It  was  shown  that  phytate  inhibits 
carcinogen-induced neoplasia in the colon and mammary gland. Then, it was also found that 
myo-inositol  inhibits  tumor  formation  to  a  similar  magnitude  under  the  same  experimental 
conditions as phytate. And it was pointed out the possibility that dephosphorylated products are 
actual inhibitors when phytate is given orally, since it was proven that phytate to be quickly 
absorbed from the stomach and upper small intestine and distributed as inositol monophosphate 
and  myo-inositol.  Subsequently,  myo-inositol  showed  very  high  potential  for  liver  cancer 
prevention, as shown in Table 1 
 
2.  Clinical  trial  for  liver  cancer  prevention:  Based  on  these  pre-clinical  results,  we  have 
decided  to  conduct  a  clinical  trial  for  liver  cancer  prevention.  In  the  first  clinical  trial,  we 
evaluated the preventive activity of carotenoid mixture (daily dose of carotenoids: 20 mg in 
total). Since the preventive potency of lycopene was very high in the experimental study (Table 
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composition  of  carotenoids  mixture  included    lycopene  10  mg,  beta-carotene  6  mg,  alpha-
carotene 3 mg, and minor portion of carotenoids, such as phytoene and  phytofluene, 1 mg. 
These carotenoids were packed with alpha-tocopherol (50 mg) into 4 capsules (Table 3). alpha-
Tocopherol was added to prevent oxidation of carotenoids. However, alpha-tocopherol itself may 
potentiate the anti-cancer potency of carotenoids mixture. 
 
Table 3. Antioxidant phytochemicals for clinical study 
______________________________________ 
Phytochemicals                            Dose 
_______________________(in 4 capsules) ___ 
Lycopene                                    10 mg 
beta-Carotene                               6 mg 
alpha-Carotene                             3 mg 
Other carotenoids                         1 mg 
alpha-Tocopherol                       50 mg 
_______________________________________ 
 
In the 4th annual analysis, significant reduction of hepatocellular carcinoma development was 
observed  in  Group  1  (treated  group).  More  than  50%  suppression  was  found  at  4  years  of 
carotenoid intervention; i.e., cumulative incidence of hepatocellular carcinoma in Group 1 was 
12.3%, while that in Group 2 (control group) was 34.6%. 
Then,  as  the  second  clinical  trial,  we  tried  to  improve  the  efficacy  for  liver  cancer 
prevention. It is of interest that   mandarin oranges contain possible candidates for liver cancer 
prevention, such as beta-cryptoxanthin and myo-inositol [9]. We decided to use a formula of 
juice for the clinical trial, which has been designed to contain 3mg of beta-cryptoxanthin and 1g 
of myo-inositol in 190 ml canned juice (Table 4). 
  
Table 4. Content of beta-cryptoxanthin and myo-inositol in Mandarin orange juice for clinical 
trial 
______________________________________ 
Phytochemicals                           Dose 
_____________________in one can (190 ml)__ 
beta-Cryptoxanthin                      3 mg 
myo-Inositol                                 1 g 
_______________________________________ 
 
Patients with viral hepatitis and cirrhosis were administered this preparation (one can per day), in 
addition to a capsule of carotenoid mixture. The patients were followed up at the clinic at regular 
intervals. Cumulative incidence of hepatocellular carcinoma development was compared with Functional Foods in Health and Disease 2011,1(12):574-581                      Page 579 of 581   
 
 
that in the group without treatment (Control group). In the data analysis at year 2.5, cumulative 
incidence  of  liver  cancer  in  beta-cryptoxanthin  and  myo-inositol-enriched  orange  juice  with 
carotenoids mixture capsules-treated group was lower than that in the control group (p=0.05), as 
shown in Table 5. The compliance of this intervention study was very good.   
 
Table 5.  Liver cancer prevention by beta-cryptoxanthin and myo-inositol-enriched Mandarin 
orange juice plus carotenoids capsule 
_________________________________________________________________________ 
Group                                                ( n )        Cumulative incidence         (Inhibition %) 
_____________________________________of liver cancer_________________________ 
 
Control group                                    (45)                   22.2 
 
Group treated with                             (24)                    4.2*                             (81%) 
beta-cryptoxanthin and myo-inositol- 
enriched Mandarin orange juice 
plus carotenoids capsule 
__________________________________________________________________________ 
Data analysis at 2.5 years of clinical intervention 
*p=0.05, comparing with control group. 
 
3.  Clinical  trial  for  lifestyle-related  diseases  prevention  using  beta-cryptoxanthin-rich 
Mandarin orange  juice: We have also found that β-cryptoxanthin-rich Mandarin orange juice 
has preventive activity against alcohol-induced gamma-GTP elevation, and obesity (body weight 
elevation, and high BMI), and as shown in Table 6 and 7. 
 
Table 6. Effect of beta-cryptoxanthin-rich Mandalin orange juice administration 
on gamma-GTP level, Body weight, and BMI.(n=7) 
______________________________________________________________ 
Condition              Before          12 Weeks of intervention       (p value)______ 
gamma-GTP           85.5                          73.7                         (p<0.005) 
Body weight           74.4                          72.9                         (p<0.001) 
BMI                        27.2                          26.6                         (p<0.001) 
______________________________________________________________ 
 
 
Table 7. Effect of beta-cryptoxanthin-rich Mandalin orange juice administration on body weight, 
and BMI. (n=60) 
______________________________________________________________ 
Condition              Before          12 Weeks of intervention       (p value)______ 
Body weight           70.6                          70.2                         (p<0.001) 
BMI                        26.9                          26.4                         (p<0.001) 
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DISCUSSION: 
Analysis of action mechanism for multi-functions of beta-cryptoxanthin is very important. As 
beta-cryptoxanthin  is  one  of  the  natural  antioxidants,  protective  activity  against  the  excess 
oxidative stress may play some role. However, further different mechanisms may also important. 
Thus, a comprehensive analysis using DNA array and   protein-antibody array seemed to be 
valuable.  For  example,  DNA  array  analysis  for  beta-cryptoxanthin  showed  the  significant 
induction of expression in various important genes, such as Rb,  p16 and p73. It is of interest that 
the pattern of modulation for DNA and protein expression has been proven to be unique and 
specific  for  each  antioxidant  and  phytochemical.These  results  support  the  strategy  of 
combination  administration  of  multiple  antioxidants  and  phytochemicals  against  cancer.  In 
conclusion,  combinational  use  of  antioxidants  and  phytochemicals  seems  to  be  a  promising 
method  for  the  prevention  of  liver  cancer  in  hepatitis  virus  infected  patients  with  cirrhosis. 
Further clinical trials are valuable and also needed to confirm and improve the efficacy. 
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